Vericel Corp Ord (VCEL)
Solvency ratios
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
---|---|---|---|---|---|
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial leverage ratio | 1.48 | 1.57 | 1.42 | 1.43 | 1.53 |
Vericel Corp Ord shows consistently low solvency ratios over the five-year period from 2020 to 2024. The Debt-to-assets ratio, Debt-to-capital ratio, and Debt-to-equity ratio all remain at 0.00 each year, indicating that the company has no significant debt relative to its total assets, capital, or equity throughout the period.
The Financial leverage ratio fluctuates slightly between 1.42 to 1.57 during the period, with a peak in 2023. This ratio measures the extent to which the company relies on debt to finance its operations. Despite the fluctuations, the ratios remain relatively low, suggesting Vericel Corp Ord maintains a conservative approach to debt financing, with a stronger reliance on equity.
Overall, the company's solvency ratios reflect a strong financial position with minimal debt obligations and a conservative capital structure. This indicates that Vericel Corp Ord is in a stable financial position with the ability to meet its financial obligations and is less vulnerable to financial distress.
Coverage ratios
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
---|---|---|---|---|---|
Interest coverage | 18.12 | -2.95 | -54.22 | -3,000.00 | 508.33 |
Vericel Corp Ord's interest coverage ratio has exhibited significant fluctuations over the past five years. The interest coverage ratio stood at a very strong 508.33 in December 31, 2020, indicating the company's ability to comfortably cover its interest payments. However, there was a drastic decline to -3,000.00 in December 31, 2021, which indicates that the company's earnings were not sufficient to cover its interest expenses, raising concerns about its financial health.
Subsequently, the interest coverage ratio improved slightly to -54.22 in December 31, 2022, although it still remained negative, reflecting ongoing challenges in meeting interest obligations. By December 31, 2023, the interest coverage ratio further improved to -2.95, suggesting a gradual recovery in the company's ability to cover interest payments. Notably, by December 31, 2024, the interest coverage ratio had improved significantly to 18.12, indicating that the company had made substantial progress in generating earnings to cover its interest expenses.
Overall, the trend in Vericel Corp Ord's interest coverage ratio has been volatile, with periods of both strength and weakness. Investors and stakeholders should monitor this ratio closely to assess the company's financial stability and ability to meet its debt obligations.